Treatment | Children with Cancer UK

Filter by Cancer Type

Developing immunotherapy for childhood sarcomas

Developing GD2-targeted cellular immunotherapy for childhood sarcomas

Professor John Anderson, Institute of Child Health, University College London

Aiming to reduce side-effects when treating children with leukaemia

Investigate the utility of vincristine pharmacokinetic and pharmacogenetic biomarkers to predict MRD status and toxicity in children with acute lymphoblastic leukaemia

Dr Sujith Samarasinghe, Great Ormond Street Hospital

Childhood cancer immunotherapy using blood cells from umbilical cord blood

T cell receptor gene therapy: novel strategies for children with cancer using engineered cord blood T cells

Professor Waseem Qasim, UCL Institute of Child Health

Can a simple blood test speed up diagnosis of Hodgkin lymphoma?

Evaluation of CCL17 as a diagnostic biomarker for classical Hodgkin lymphoma

Professor Ruth Jarrett, University of Glasgow Garscube Estate

Using international teamwork to treat brain tumours

BIOMarkers of Ependymomas in Children and Adolescents (BIOMECA) - Integrated Biological study within SIOP Ependymoma II trial organised by European Ependymoma Biology

Professor Richard Grundy, Children’s Brain Tumour Research Centre, University of Nottingham

Accelerating the delivery of personalised treatment to children with neuroblastoma using MRI

Accelerating Personalised Treatment for Children with Neuroblastoma with MRI Biomarkers

Dr Yann Jamin, Institute of Cancer Research

1 … 16 17 18 19